These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24163666)

  • 1. Hypersensitivity to Etoposide in case of metastatic gestational choriocarcinoma.
    Lazović B; Milenković V; Delić M; Mazić S; Jeremic K; Hrgović Z
    Case Rep Oncol; 2013; 6(3):490-2. PubMed ID: 24163666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful rechallenge with etoposide phosphate after an acute hypersensitivity reaction to etoposide.
    Bernstein BJ; Troner MB
    Pharmacotherapy; 1999 Aug; 19(8):989-91. PubMed ID: 10453971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide.
    Siderov J; Prasad P; De Boer R; Desai J
    Br J Cancer; 2002 Jan; 86(1):12-3. PubMed ID: 11857004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease.
    Hudson MM; Weinstein HJ; Donaldson SS; Greenwald C; Kun L; Tarbell NJ; Humphrey WA; Rupp C; Marina NM; Wilimas J
    J Clin Oncol; 1993 Jun; 11(6):1080-4. PubMed ID: 8501494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hypotensive reaction to etoposide with successful rechallenge: case report and review of the literature.
    Cersosimo RJ; Calarese P; Karp DD
    DICP; 1989 Nov; 23(11):876-7. PubMed ID: 2688329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with etoposide phosphate in patients with previous etoposide hypersensitivity.
    Collier K; Schink C; Young AM; How K; Seckl M; Savage P
    J Oncol Pharm Pract; 2008 Mar; 14(1):51-5. PubMed ID: 18337441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoposide-induced hypersensitivity reactions. Report of two cases.
    Tucci E; Pirtoli L
    Chemioterapia; 1985 Dec; 4(6):460-2. PubMed ID: 3830414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anaphylaxia induced by etoposide--a case report].
    Taguchi A; Takeshita S; Machida R; Hori Y; Aida K; Furuya U; Ohe E; Murase T; Shinozuka N; Ayabe T; Mori H
    Gan To Kagaku Ryoho; 2003 Aug; 30(8):1187-9. PubMed ID: 12938279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity.
    Brooks JP; Azmy V; Thompson A; Luon D; Prozora SD; Price C; Hsu FI
    J Oncol Pharm Pract; 2020 Jan; 26(1):228-231. PubMed ID: 30885040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebral hemorrhage as initial presentation of gestational choriocarcinoma: a case report and literature review.
    Huang CY; Chen CA; Hsieh CY; Cheng WF
    Int J Gynecol Cancer; 2007; 17(5):1166-71. PubMed ID: 17425677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersensitivity reactions to etoposide phosphate.
    Sambasivan K; Mahmoud S; Kokache A; Seckl M; Savage P
    J Oncol Pharm Pract; 2014 Apr; 20(2):158-60. PubMed ID: 23740378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Etoposide desensitization. A case report].
    Alvarez Cardona A; Hernández Nieto L; Pérez Gómez M; Pedroza Meléndez A; Huerta López JG
    Rev Alerg Mex; 2010; 57(1):33-6. PubMed ID: 20857627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience.
    Polyzos A; Tsavaris N; Kosmas C; Arnaouti T; Kalahanis N; Tsigris C; Giannopoulos A; Karatzas G; Giannikos L; Sfikakis PP
    Oncology; 2001; 61(2):129-33. PubMed ID: 11528251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral etoposide for metastatic choriocarcinoma: a case report and review of guidelines.
    Breitbach GP; Sklavounos P; Veith C; Costa SD; Kuhn W; Solomayer EF; Juhasz-Boess I; Tempfer C
    Arch Gynecol Obstet; 2019 Apr; 299(4):1115-1119. PubMed ID: 30569343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of a Type I Hypersensitivity Reaction to IV Etoposide in a Woman with a Yolk Sac Tumor: A Case Report.
    Starks D; Prinz D; Armstrong A; Means L; Waggoner S; Debernardo R
    Case Rep Obstet Gynecol; 2011; 2011():837160. PubMed ID: 22567517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic Brain Choriocarcinoma in a Postmenopausal Woman: A Case Report.
    Dombrovsky I; Tilden HR; Aftandilians T; Wong S; Stowe RJ
    Am J Case Rep; 2020 Jan; 21():e917656. PubMed ID: 31986128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with pembrolizumab after hypersensitivity reaction to nivolumab in a patient with hepatocellular carcinoma.
    Choi B; McBride A; Scott AJ
    Am J Health Syst Pharm; 2019 Oct; 76(21):1749-1752. PubMed ID: 31612928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fallopian tube choriocarcinoma presenting as ovarian tumour: a case report.
    Mundkur A; Rai L; Hebbar S; Guruvare S; Adiga P
    J Clin Diagn Res; 2015 Jan; 9(1):QD01-2. PubMed ID: 25738040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brentuximab Vedotin Infusion Reaction Management: A Case Study.
    Comer H; Cardwell K
    J Adv Pract Oncol; 2017; 8(6):626-629. PubMed ID: 30310723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gestational choriocarcinoma with renal and pulmonary metastases lacking a primary uterine origin.
    Li HM; Hou WC; Lai YJ; Kao CC; Chao TK; Yu MH; Su HY
    Taiwan J Obstet Gynecol; 2016 Dec; 55(6):881-885. PubMed ID: 28040140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.